CSL (CSLLY) Stock Forecast & Price Target $17.69 0.00 (0.00%) As of 05/22/2026 04:00 PM Eastern Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartHeadlinesSEC FilingsShort InterestBuy This Stock CSL - Analysts' Recommendations and Stock Price Forecast (2026) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating ReduceBased on 4 Analyst RatingsSell1Hold3Buy0 Based on 4 Wall Street analysts who have issued ratings for CSL in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 4 analysts, 1 has given a sell rating, and 3 have given a hold rating for CSLLY. Consensus Price Target N/A MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for CSLLY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CSL and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CSLLY Analyst Ratings Over TimeTypeCurrent Forecast5/25/25 to 5/25/261 Month Ago4/25/25 to 4/25/263 Months Ago2/24/25 to 2/24/261 Year Ago5/25/24 to 5/25/25Strong Buy0 Strong Buy rating(s)1 Strong Buy rating(s)1 Strong Buy rating(s)2 Strong Buy rating(s)Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s)0 Buy rating(s)Hold3 Hold rating(s)2 Hold rating(s)2 Hold rating(s)0 Hold rating(s)Sell1 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price TargetN/AN/AN/AN/AForecasted UpsideN/AN/AN/AN/AConsensus RatingReduceModerate BuyModerate BuyStrong Buy CSLLY Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History CSLLY Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table CSL Stock vs. The CompetitionTypeCSLMedical CompaniesBroader MarketConsensus Rating Score 1.75 2.30 2.52Consensus RatingReduceHoldModerate BuyPredicted UpsideN/A1,714.95% Upside15.09% UpsideNews Sentiment RatingNeutral NewsSee Recent CSLLY NewsNeutral NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails5/11/2026 Canaccord Genuity Group4 of 5 stars DowngradeStrong-Buy ➝ Hold5/11/2026 Zacks ResearchNot Rated DowngradeHold ➝ Strong Sell5/11/2026 Citigroup4 of 5 stars DowngradeStrong-Buy ➝ Hold2/11/2026 Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating DowngradeModerate Buy ➝ Hold1/16/2025 The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingD. ThillainathanSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeStrong-Buy8/13/2024 Macquarie InfrastructureSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingD. BaileySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeStrong-BuyAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:57 AM ET. Should I Buy CSL Stock? CSLLY Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, May 18, 2026. Please send any questions or comments about these CSL pros and cons to contact@marketbeat.com. CSL Bull Case Here are some ways that investors could benefit from investing in CSL Limited: The current stock price is around $79.55, which may present a favorable entry point for investors looking to capitalize on potential growth. CSL Limited operates in the biopharmaceutical sector, which has shown resilience and growth potential, particularly in areas like gene therapies and plasma products. The company has a diverse product portfolio across its segments, including CSL Behring, CSL Seqirus, and CSL Vifor, which helps mitigate risks associated with reliance on a single product line. CSL Limited has a strong international presence, with operations in key markets such as the United States, Germany, and China, allowing for broader revenue opportunities. Recent performance metrics indicate a positive trend, with a notable increase in shares shorted, suggesting growing investor interest and confidence in the company's future prospects. CSL Bear Case Investors should be bearish about investing in CSL Limited for these reasons: Institutional ownership is currently at 0%, which may indicate a lack of confidence from larger investors in the company's future performance. The company has a relatively low short percentage of float, which could suggest limited market interest or potential for volatility in stock price movements. CSL Limited's recent performance shows only a slight increase in shares shorted, which may not be sufficient to indicate strong bullish sentiment among investors. With an average daily volume of 139,400, liquidity could be a concern for investors looking to enter or exit positions quickly. The company has reported a modest 52-week performance, which may not be compelling enough to attract aggressive growth investors. CSLLY Forecast - Frequently Asked Questions Should I buy or sell CSL stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CSL in the last year. There is currently 1 sell rating and 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" CSLLY shares. Does CSL's stock price have much downside? According to analysts, CSL's stock has a predicted downside of -100.00% based on their 12-month stock forecasts. Has CSL been downgraded by Wall Street analysts recently? Over the previous 90 days, CSL's stock had 3 downgrades by analysts. What analysts cover CSL? CSL has been rated by research analysts at Canaccord Genuity Group, Citigroup, and Zacks Research in the past 90 days. Do Wall Street analysts like CSL more than its competitors? Analysts like CSL less than other "medical" companies. The consensus rating for CSL is Reduce while the average consensus rating for "medical" companies is Hold. Learn more on how CSLLY compares to other companies. Stock Forecasts and Research Tools Related Companies Bristol Myers Squibb Stock Forecast Vertex Pharmaceuticals Stock Forecast GSK Stock Forecast Regeneron Pharmaceuticals Stock Forecast argenex Stock Forecast Alnylam Pharmaceuticals Stock Forecast Revolution Medicines Stock Forecast Royalty Pharma Stock Forecast Biogen Stock Forecast Insmed Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With CSL RecommendationsZacks ResearchCanaccord Genuity GroupCitigroupRoyal Bank Of Canada This page (OTCMKTS:CSLLY) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share CSL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
